There are currently 967 clinical trials in Salt Lake City, Utah looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Utah, Huntsman Cancer Institute/University of Utah, Huntsman Cancer Institute and LDS Hospital. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study
NCT05608460
Recruiting
A prospective multicenter observational study, led by Dr. Katie Russell of Intermountain Primary Children's Hospital, that will examine the sensitivity, specificity, negative, and positive predictive values of CT scan and plain films in diagnosing cervical spine injury that requires treatment. This study is funded by the Primary Children's Hospital foundation.
Gender:
All
Ages:
Between 0 years and 17 years
Trial Updated:
11/01/2022
Locations: Primary Children's Hospital, Salt Lake City, Utah
Conditions: Cervical Spine Fracture
Register for Updates
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
NCT04012996
Recruiting
A multi-center, prospective, randomized, controlled comparison of the prodisc C SK and prodisc C Vivo to the control, a similar, legally marketed total disc replacement device in subjects with symptomatic cervical disc disease (SCDD).
Gender:
All
Ages:
Between 18 years and 69 years
Trial Updated:
10/27/2022
Locations: The Disc Replacement Center, Salt Lake City, Utah
Conditions: Symptomatic Cervical Disc Disease
Register for Updates
Project MARS: Mobile-Assistance for Regulating Smoking
NCT04376489
Recruiting
This study aims to identify states of vulnerability for lapse, identify states of receptivity for engaging in self-regulatory activities, and investigate approaches to capitalize on states of vulnerability and receptivity to deliver real-time self-regulation prompts among smokers.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2022
Locations: University of Utah, Salt Lake City, Utah
Conditions: Current Smoker, Tobacco Smoking
Register for Updates
Establish ProLung Test Measurement Collection Protocol for Future Studies.
NCT04134520
Recruiting
The purpose of this Study is to identify and test different data collection methods to determine which approaches improve the ProLung Testing procedure. Once this Study is complete, the Sponsor plans to evaluate these improvements in future follow up Validation studies that will assess device accuracy using the new measurement collection methods.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/21/2022
Locations: Michael Garff, Salt Lake City, Utah
Conditions: Cancer , Healthy
Register for Updates
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
NCT01860612
Recruiting
The purpose of this study is to study the long term safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.
Gender:
All
Ages:
3 years and above
Trial Updated:
10/21/2022
Locations: The Eye Institute of Utah, Salt Lake City, Utah
Conditions: Full Aniridia, Partial Aniridia
Register for Updates
Eating Mindfully to Prevent Weight Regain
NCT04847843
Recruiting
The overall objective of this study is to evaluate the efficacy of a mindfulness-based intervention to prevent weight regain in weight-reduced adults.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/12/2022
Locations: University of Utah, Salt Lake City, Utah
Conditions: Weight Loss, Weight Gain, Eating Behavior, Obesity, Bariatric Surgery Candidate
Register for Updates
Surveillance AFter Extremity Tumor surgerY
NCT03944798
Recruiting
Following treatment for a primary extremity sarcoma, patients remain at risk for the development of local and systemic disease recurrence. Metastasis (distant recurrence) to the lung is the most frequent single location of disease recurrence in sarcoma patients, occurring in almost half of all patients. Therefore, careful post-operative surveillance is an integral element of patient care. However, the detection of metastases does not necessarily affect long-term survival and may negatively impac... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/04/2022
Locations: Huntsman Cancer Institute, Salt Lake City, Utah
Conditions: Soft Tissue Sarcoma, Lung Metastases
Register for Updates
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
NCT05070455
Recruiting
This is a Phase IV, multicenter, open-label study of Asceniv™ administered as an intravenous infusion of Asceniv™ (IGIV) 300-800 mg/kg every 21 or 28 days in approximately 12 pediatric subjects with Primary Immunodeficiency Diseases (PIDD). The study will be conducted at 5-7 centers in the United States, with subjects receiving six (28 day cycle) or seven (21 day cycle) doses of Asceniv™ during the study.
Gender:
All
Ages:
Between 2 years and 11 years
Trial Updated:
09/13/2022
Locations: University of Utah, Salt Lake City, Utah
Conditions: Primary Immune Deficiency
Register for Updates
Targeting the Nine Hallmarks of Aging on DNA Methylation
NCT05535608
Recruiting
SRW Laboratories has formulated the Cel System protocol, a group of three formulas designed to interact with each of the 9 Hallmarks of Aging and combined this with an App that supports positive lifestyle changes, with a view that, if we can positively impact each Hallmark, we can support healthy aging.
Gender:
All
Ages:
Between 55 years and 90 years
Trial Updated:
09/09/2022
Locations: Regenerative Wellness Center, Salt Lake City, Utah
Conditions: Aging
Register for Updates
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection
NCT03988855
Recruiting
This is an open-label study to evaluate the safety, efficacy, and PK of DNV3837 at a dose of 1.5 mg/kg actual body weight(BW)/day administered via IV infusion in subjects with CDI. The study will be conducted in 2 subsequent parts. In Part 1 of the study, 10 subjects of either sex with severe or non-severe CDI will be enrolled to receive DNV3837. In Part 2 of the study, up to 30 subjects with severe or non-severe CDI will be enrolled to receive DNV3837. In both parts of the study, treatment i... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/06/2022
Locations: University of Utah, Salt Lake City, Utah
Conditions: Clostridium Difficile (C. Difficile)
Register for Updates
Normal Quantitative EEG (qEEG) Dataset
NCT02375126
Recruiting
In this study, the investigators will collect EEG data in normal, healthy volunteers without a history of prior brain injury. This data will be analyzed by computer (quantitative, or qEEG) and stored in a normative database so that, in the future, the investigators can better understand and characterize the brain damage that can result from carbon monoxide (CO) poisoning and other types of brain injury.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
08/08/2022
Locations: Intermountain Healthcare, LDS Hospital, Salt Lake City, Utah
Conditions: Carbon Monoxide Poisoning
Register for Updates
Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines
NCT02563678
Recruiting
In this small pilot study, participants (patients and healthy volunteers) will have blood drawn before and after the study intervention (hyperbaric chamber session or normal pressure oxygen breathing. This blood will be analyzed for neutrophil oxidative burst and cytokine analysis.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
08/02/2022
Locations: Intermountain Healthcare, LDS Hospital, Salt Lake City, Utah
Conditions: Infection
Register for Updates